Influenza Vaccination in Patients Living With HIV in the Northern Region: An Observational Monocentre Study of Blankets, Modalities, Drivers and Brakes
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- HIV
- Sponsor
- Tourcoing Hospital
- Enrollment
- 124
- Locations
- 1
- Primary Endpoint
- questionnaire influenza vaccine coverage
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
Anyone living with the Human Immunodeficiency Virus (HIV) has an indication for annual influenza vaccination. (Vaccination schedule and vaccination recommendations 2019). Influenza is a viral infection that has a significant impact on the health care system. However, vaccination coverage in France is still insufficient with regard to the objectives set at 75% by the WHO and the European Commission. For the 2019-2020 seasonal influenza vaccination campaign, flu vaccination by volunteer pharmacists has become possible throughout the country. Studies that have estimated vaccination coverage among HIV-positive populations are rare and show very low rates.
Detailed Description
Cross-sectional study via a self-questionnaire given to all HIV-infected patients coming for a scheduled consultation as part of their HIV follow-up in the spring of 2020. Non-opposition letter given to the patient. Collection of data a posteriori from the medical file recorded in the eNadis patient file.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Any adult person living with HIV presenting for a follow-up consultation in the spring of 2020
- •People who do not read French may participate if they wish with the help of a medical or paramedical staff member.
- •Patient did not object
Exclusion Criteria
- •Minor patients
- •Major under guardianship, curatorship, protected person
Outcomes
Primary Outcomes
questionnaire influenza vaccine coverage
Time Frame: through study completion, an average of 1 year
The objective of this questionnaire is to estimate the influenza vaccine coverage among PVVIH followed at the Tourcoing Hospital Center.
Secondary Outcomes
- modalities of influenza vaccination(through study completion, an average of 1 year)
- the drivers and disincentives to influenza vaccination(through study completion, an average of 1 year)